Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
6/28/2022
Palleon and Henlius Enter into Strategic Collaboration to Develop Bifu...
6/27/2022
NMPA Issues Three New Documents on Drug Tracing and Vaccine Production...
6/27/2022
CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...
6/27/2022
Snapshot of Patient Expenditures of Level II and Above Public Hospital...
6/27/2022
Amgen Strikes Outliciensing Deal with Fosun for Otezla and Parsabiv in...
6/27/2022
Zai Lab Announces Primary Listing on the Main Board of HKEx
6/27/2022
Antengene Enters Clinical Partnership with BeiGene to Evaluate Selinex...
6/24/2022
CDE's Annual Review of Chinese Drug Evaluation & Registration in 2021 ...
6/24/2022
Drug R&D and Product Registration News Digest June 2022 (3)
6/24/2022
Huadong and Julphar Announce Strategic Cooperation of Liraglutide in M...
6/24/2022
At ASCO 2022, Chinese Biotech Firms Deliver Rosy Data On PD-(L)1, Cell...
6/23/2022
The Great Wall: Why Overseas Sponsors Are Yet to Fully Tap into China'...
6/23/2022
Sino Biopharmaceutical to Acquire F-Star Therapeutics for $161M
6/23/2022
NMPA Announces Package Insert Revision of Glucosamine Formulations
6/23/2022
CDE Issues the Technical Guidelines for Protocol Changes During Clinic...
6/23/2022
GlobalData: Borrena (lorlatinib) Approval Further Strengthens Pfizer P...
6/23/2022
Deloitte Maps Out Four Likely Scenarios for China's Health Ecosystem i...
6/22/2022
CDE Solicits Comments on Three Draft Technical Guidelines for Bioequiv...
6/22/2022
China Likely to Ban Third-Party Platforms in Online Drug Sales: Report...
6/22/2022
China's Mental-health Crisis Is Getting Worse (Economist)
6/21/2022
China's May Fundraising Indicates Interest in Early-stage Biotech
6/21/2022
Xuanzhu Biopharma Out-licenses Greater China Rights of Two Anti-infect...
6/21/2022
Innovent and Lilly Jointly Announce Chinese Approval of TYVYT Combo wi...
6/21/2022
JPO Issues Bidding Documents for the 7th Round of Volume-Based Procure...
6/21/2022
AstraZeneca to Open New Regional Headquarters in Qingdao
6/20/2022
CDE Solicits Comments on the Draft Technical Guidelines for Applicabil...
6/20/2022
CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...
6/20/2022
CDE Solicits Comments on the Draft Procedures for Application and Mana...
6/18/2022
Chinese Researchers Use Supercomputer and AI to Expedite Drug Discover...
6/18/2022
Drug R&D and Product Registration News Digest June 2022 (2)
Page:
80
/
719
Total number of articles:
21546
:
[First]
[<<]
[78]
[79]
[80]
[81]
[82]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit